產(chǎn)品詳情
簡(jiǎn)單介紹:
Anti-GAB3抗體產(chǎn)品質(zhì)量穩(wěn)定,實(shí)驗(yàn)效果明顯,貨期快,價(jià)格優(yōu)惠,歡迎垂詢訂購(gòu)!我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-GAB3抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹:
Rabbit Anti-GAB3
Cat. Number:
Anti-GAB3抗體KL-13255R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The Gab family of adaptor proteins function as molecular scaffolds that mediate protein recrutiment to RTKs (1–3). Cytokine/growth factor triggering of protein tyrosine kinase receptors (RTKs) initiates signaling cascades that Anti-GAB3抗體progress to the nucleus where signals for activation, proliferation and differentiation occur (1–3). This scaffolding mechanism represents a critical link in cytokine/growth factor signaling routes. Gab1-3 contain pleckstrin homology and potential binding sites for SH2 and SH3 domain-containing proteins (1,4,5). The recruitment of signaling partners to Gab family members is phosphorylation dependent (1,4). Insulin receptor and EGF-receptor signaling are among the cascades that rely on Gab family members to elicit a nuclear response to an extracellular stimulus (6,7). The human Gab3 gene maps to chromosome Xq28 and encodes a 586 amino acid protein (5).
Also known as:
Gab3; GAB3_HUMAN; Anti-GAB3抗體GRB2-associated binder 3; GRB2-associated-binding protein 3; Growth factor receptor bound protein 2-associated protein 3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human GAB3.
●
Predicted Molecular Weight: 66kDa.Anti-GAB3抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-GAB3抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-GAB3抗體
Optimal working dilutions must be determined by the end user.
kl122Hu01 序列相似家族132成員A(FAM132A)多克隆抗體 Polyclonal Antibody to Family With Sequence Similarity 132, Member A (FAM132A)
kl236Hu01 半乳糖凝集素9C(GAL9C)多克隆抗體 Polyclonal Antibody to Galectin 9C (GAL9C)
kl381Hu01 胃泌酸調(diào)節(jié)素(OXM)多克隆抗體 Polyclonal Antibody to Oxyntomodulin (OXM)
kl002Bo01 白細(xì)胞激活黏附因子(ALCAM)多克隆抗體 Polyclonal Antibody to Activated Leukocyte Cell Adhesion Molecule (ALCAM)
kl002Hu01 白細(xì)胞激活黏附因子(ALCAM)多克隆抗體 Polyclonal Antibody to Activated Leukocyte Cell Adhesion Molecule (ALCAM)
kl002Mu01 白細(xì)胞激活黏附因子(ALCAM)多克隆抗體 Polyclonal Antibody to Activated Leukocyte Cell Adhesion Molecule (ALCAM)
kl002Ra01 白細(xì)胞激活黏附因子(ALCAM)多克隆抗體 Polyclonal Antibody to Activated Leukocyte Cell Adhesion Molecule (ALCAM)
kl002Rb51 白細(xì)胞激活黏附因子(ALCAM)多克隆抗體 Polyclonal Antibody to Activated Leukocyte Cell Adhesion Molecule (ALCAM)
kl004Bo01 血管緊張素轉(zhuǎn)化酶(ACE)多克隆抗體 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)
kl004Hu01 血管緊張素轉(zhuǎn)化酶(ACE)多克隆抗體 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)
kl004Mu01 血管緊張素轉(zhuǎn)化酶(ACE)多克隆抗體 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)
kl004Po01 血管緊張素轉(zhuǎn)化酶(ACE)多克隆抗體 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)
kl004Ra01 血管緊張素轉(zhuǎn)化酶(ACE)多克隆抗體 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)
kl004Rb51 血管緊張素轉(zhuǎn)化酶(ACE)多克隆抗體 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)
kl006Bo01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Eq01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Ga01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Hu01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Mu01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Po01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)



